Back to Search Start Over

Impact on genitourinary function and quality of life following focal irreversible electroporation of different prostate segments

Authors :
Ilan Gielchinsky
Matthijs J. Scheltema
Theo de M Reijke
Maret Böhm
Jean de la Rosette
Tuan V. Nguyen
John I. Chang
Phillip D. Stricker
Willemien van den Bos
Amila Siriwardana
Scheltema, Matthijs J.
Chang, John I.
van den Bos, Willemien
Gielchinsky, Ilan
Nguyen, Tuan V.
Siriwardana, Amila R.
Bohm, Maret Garvan Inst Med Res, Darlinghurst, NSW, Australia
Bohm, Maret Kinghorn Canc Ctr, Darlinghurst, NSW, Australia
Stricker, Phillip D. St Vincents Prostate Canc Ctr, Darlinghurst, NSW, Australia
de Reijke, Theo M.
de la Rosette, Jean J. Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands
Siriwardana, Amila R. Univ New South Wales, Sydney, NSW, Australia
Nguyen, Tuan V. Univ Technol, Sydney, NSW, Australia
de la Rosette, Jean J. Istanbul Medipol Univ, Dept Urol, Istanbul, Turkey
Stricker, Phillip -- 0000-0002-0934-0656
ACS - Atherosclerosis & ischemic syndromes
Graduate School
APH - Personalized Medicine
APH - Quality of Care
CCA - Cancer Treatment and Quality of Life
Radiology and Nuclear Medicine
Urology
Biomedical Engineering and Physics
Source :
Diagnostic and interventional radiology (Ankara, Turkey), 24(5), 268-275. Turkish Society of Radiology
Publication Year :
2018

Abstract

Annual Meeting of the Western-Section of the American-Urological-Association (AUA) -- AUG 06-10, 2017 -- Vancouver, CANADA WOS: 000444189400004 PubMed ID: 30211680 PURPOSE We aimed to evaluate the genitourinary function and quality of life (QoL) following the ablation of different prostate segments with irreversible electroporation (IRE) for localized prostate cancer (PCa). METHODS Sixty patients who received primary focal IRE for organ-confined PCa were recruited for this study. Patients were evaluated for genitourinary function and QoL per prostate segment treated (anterior vs. posterior, apex vs. base vs. apex-to-base, unilateral vs. bilateral). IRE system settings and patient characteristics were compared between patients with preserved vs. those with impaired erectile function and urinary continence. Data were prospectively collected at baseline, 3, 6, and 12 months using the expanded prostate cancer index composite, American Urological Association symptom score, SF-12 physical and mental component summary surveys. Difference over time within segments per questionnaire was evaluated using the Wilcoxon's signed rank test. Outcome differences between segments were assessed using covariance models. Baseline measurements included questionnaire scores, age, and prostate volume. RESULTS There were no statistically significant changes over time for overall urinary (P = 0.07-0.89), bowel (P = 0.06-0.79), physical (P = 0.18-0.71) and mental (P = 0.45-0.94) QoL scores within each segment. Deterioration of sexual function scores was observed at 6 months within each segment (P = 0.001-0.16). There were no statistically significant differences in QoL scores between prostate segments (P = 0.08-0.97). Older patients or those with poor baseline sexual function at time of treatment were associated with a greater risk of developing erectile dysfunction. CONCLUSION IRE is a feasible modality for all prostate segments without any significantly different effect on the QoL outcomes. Older patients and those with poor sexual function need to be counseled regarding the risk of erectile dysfunction. American Urological Association, Western Sect Australian Prostate Cancer Research Centre-NSW; St. Vincent's Prostate Cancer Centre The Australian Prostate Cancer Research Centre-NSW and the St. Vincent's Prostate Cancer Centre funded this research project.

Details

ISSN :
13053612 and 13053825
Volume :
24
Issue :
5
Database :
OpenAIRE
Journal :
Diagnostic and interventional radiology (Ankara, Turkey)
Accession number :
edsair.doi.dedup.....29b4b1f474e6783f715d4cad17ce32a0